AFP and neoplasm: Hiraoka et al. (24) reported that patients with more than two positive tumor markers, containing AFP (≥100 ng/mL), fucosylated alpha fetoprotein (≥10%), and des-gamma-carboxy prothrombin (≥100 mAU/mL) may have a higher probability to develop TACE refractoriness.